KRS 218A.171: Electronic prescribing.

(1) Electronic prescribing of a controlled substance under this chapter shall not interfere

with a patient's freedom to select a pharmacy.

(2) Electronic prescribing software used by a practitioner to prescribe a controlled

substance under this chapter may inc lude clinical messaging and messages in pop -

up windows directed to the practitioner regarding a particular controlled substance

that supports the practitioner's clinical decision making.

(3) Drug information contained in electronic prescribing software to prescribe a

controlled substance under this chapter shall be consistent with Food and Drug

Administration-approved information regarding a particular controlled substance.

(4) (a) Electronic prescribing software used by a practitioner to prescribe a controlled

substance under this chapter may show information regarding a payor's

formulary, copayments, or benefit plan, provided that nothing in the software

is designed to preclude a practitioner from selecting any particular pharmacy

or controlled substance.

(b) If electronic prescribing software does show information regarding a payor's

formulary, payments, or benefit plan under paragraph (a) of this subsection,

the information shall be updated at least quarterly to ensure its accuracy.

(5) Each governmental unit of the Commonwealth promulgating administrative

regulations relating to electronic prescribing shall include in the regulations

electronic prior authorization standards meeting the requirements of KRS 304.17A -

167 in its implementation of health inform ation technology improvements as

required by the Medicare Prescription Drug, Improvement, and Modernization Act

of 2003 and the Health Information Technology for Economic and Clinical Health

Act, enacted as part of the American Recovery and Reinvestment Act of 2009.